⬡ GrantFinder
Dashboard
SAP Sequence
Scout
Memory
Profile
2026-06-29
Applicant Profile
Used by scouts, researchers and the application agent to determine fit and fill forms
Personal Information
Full Name
Email
Phone
Nationality
Location
Date of Birth
GitHub
Website
ORCID
LinkedIn URL
Short Bio (2–3 sentences)
AI Profile Texts
These texts are sent to Claude for fit scoring and application drafting. Keep them accurate and up-to-date.
Researcher Profile (for fellowships, grants, competitions)
Name: Eniola Ayodele Olutogun Affiliation: Independent researcher, Lagos / ZYCO ORCID: 0009-0001-9272-6735 | GitHub: github.com/AmunRaPtah | zyco.org Nationality: Nigerian | Age: 29 | Currently: Lagos, Nigeria DEGREE: B.Pharm, University of Ibadan (2014–2021), CGPA 5.1/7.0 (2:1 Upper Division), German equivalent 1.9. PCN-licensed pharmacist. INDEPENDENT RESEARCH (2025–2026): The Conjunctive Consolidation Threshold (CCT) model — a tripartite pharmacological framework for reward-memory encoding prevention in addiction. Three sole-authored preprints on OSF/Zenodo: • Foundational CCT paper (OSF 10.17605/OSF.IO/KG7B5) • Formal mathematical specification (OSF 10.17605/OSF.IO/EMY4U) • Bayesian population dynamics + clinical trial architecture (Zenodo 10.5281/zenodo.20492472) Review article under review at Neuroscience & Biobehavioral Reviews. ODE/RK45 + Bayesian MCMC validation; encoding probability 0.855→0.122 (85.8% reduction); super-additivity +12.8 pp; all pre-registered hypotheses H1–H5 confirmed. Co-authored paper in Alcohol (Elsevier, under review). PLATFORMS BUILT: IMPRINT (addiction-liability screening); TOPOLOGIX (TDA for drug-protein interaction, persistent homology + bipartite simplicial complexes, hERG cardiotoxicity MVP); GATE (BCI neural- stimulation safety evaluation, Apache 2.0). COLLABORATORS / ENDORSEMENTS: Kent Berridge (Michigan), Samuel Gershman (Harvard, arXiv endorsement), Nathaniel Daw (Princeton), Marcelo Mattar (NYU). Provisional patent on CCT core architecture Q3 2026. SKILLS: Python (scipy, numpy, ODE/RK45, PyMC/MCMC, pandas), R, TDA (Ripser, Gudhi), NEURON/Brian2, AlphaFold, RDKit, ADMET/QSAR, GROMACS, AutoDock, Nextflow/SLURM/HPC, Supabase/Postgres, JavaScript/Node.js. EMPLOYMENT: National Product Manager, Synthcare (Mar 2026–present); Clinical Pharmacist, Ramset Pharmacy (Jan–Mar 2026); Research Asst. CDDDP (NMDA/insulin docking); Bioinformatics Researcher GHRU-GSAR (AMR genomics, surveillance pipeline). SEEKING (researcher track): Fellowships ($10K–$100K), research grants, training courses, competitions, residencies for an independent computational neuroscience / pharmacology researcher. Strong Africa/Nigeria angle. Not yet enrolled in MSc (applying Oct 2026 start at MUG/Graz, Austria). Eligible for early-career, pre-PhD, LMIC-track, and independent researcher programmes.
Startup Profile (for incubators, accelerators, VCs)
Venture: Pre-seed AI/biotech startup predicting drug resistance mutations from protein sequence alone (no crystal structure required). Referred to generically as "the venture" in applications. Founder: Eniola Olutogun — pharmacist-turned-ML engineer, sole author, planning Île-de-France / EU. Stage: pre-seed, proof-of-concept validated, not yet incorporated. TECHNOLOGY: ESM-2 protein language model delta-embeddings + ECFP4 drug fingerprints, Random Forest classifier. AUROC 0.634 on Platinum benchmark (357 mutations, protein-grouped CV). 100% mutation coverage vs 17.6% for structure-limited tools. Comparable to published SOTA (mCSM-lig AUROC 0.70). SECTOR: BioTech, computational biology, pharma AI, drug discovery, oncology, antivirals, AMR. GEOGRAPHY: Targeting EU (France / Île-de-France priority), UK, US programs. SEEKING: Grants €30K–€2.5M non-dilutive preferred; incubators with biopharma network; accelerators with compute credits; pre-seed VCs with biotech/AI thesis; competitions in computational drug discovery. ROADMAP: Fine-tune ESM-2 on SKEMPI 3K mutations → AUROC ≥0.70 → Servier pilot → ARR. NAMED PARTNERS: Servier (Suresnes), Paris-Saclay (I2BC, Institut Pasteur), Sanofi (Gentilly). SUPPORT PIPELINE: SEMIA / Quest for Health meeting in progress; WILCO One BioTech Oct 2026; IncubAlliance + AI House applications submitted; EIC Accelerator + BPI i-Lab as future targets.
Save Profile
Documents
Upload your CV, cover letter, transcripts etc. The application agent uses these to fill file upload fields automatically.
NIH Biosketch — L.I.F.E. Research Grants
biosketch · biosketch_GP-02.pdf
LOI — L.I.F.E. Research Grants
letter_of_intent · loi_GP-02.pdf
Technical One-Pager — SEMIA / Quest for Health Incubator
one_pager · onepager_ST-01_20260628.pdf
Technical One-Pager — SEMIA / Quest for Health Incubator
one_pager · onepager_ST-01_20260628.pdf
Technical One-Pager — SEMIA / Quest for Health Incubator
one_pager · onepager_ST-01_20260628.pdf
Pitch Deck — SEMIA / Quest for Health Incubator
pitch_deck · deck_ST-01_20260628.pdf
Display Name
Type
CV / Resume
Cover Letter
Photo
Transcript
Recommendation Letter
Research Statement
Other
File
Upload Document
Notification Config
Telegram:
Configured
Email:
Not configured — set SMTP_USER + SMTP_PASS
Playwright:
Installed